» Articles » PMID: 40070830

Cellular and Molecular Determinants Mediating the Dysregulated Germinal Center Immune Dynamics in Systemic Lupus Erythematosus

Abstract

Introduction: Systemic lupus erythematosus (SLE) is characterized by dysregulated humoral immunity, leading to the generation of autoreactive B cells that can differentiate both within and outside of lymph node (LN) follicles.

Methods: Here, we employed spatial transcriptomics and multiplex imaging to investigate the follicular immune landscaping and the transcriptomic profile in LNs from SLE individuals.

Results: Our spatial transcriptomic analysis revealed robust type I IFN and plasma cell signatures in SLE compared to reactive, control follicles. Cell deconvolution revealed that follicular T cell subsets are mainly affected by the type I IFN fingerprint of SLE follicles. Dysregulation of T differentiation was documented by i) the significant reduction of Bcl6 T cells, ii) the reduced cell density of potential IL-4 producing T cell subsets associated with the impaired transcriptomic signature of follicular IL-4 signaling and iii) the loss of their correlation with GC-B cells. This profile was accompanied by a marked reduction of Bcl6 B cells and an enrichment of extrafollicular CD19CD11cTbet, age-associated B cells (ABCs), known for their autoreactive potential. The increased prevalence of follicular IL-21 cells further reveals a hyperactive microenvironment in SLE compared to control.

Discussion: Taken together, our findings highlight the altered immunological landscape of SLE follicles, likely fueled by potent inflammatory signals such as sustained type I IFN and/or IL-21 signaling. Our work provides novel insights into the spatial molecular and cellular signatures of SLE follicular B and T cell dynamics, and points to druggable targets to restore immune tolerance and enhance vaccine responses in SLE patients.

References
1.
Niewold T, Adler J, Glenn S, Lehman T, Harley J, Crow M . Age- and sex-related patterns of serum interferon-alpha activity in lupus families. Arthritis Rheum. 2008; 58(7):2113-9. PMC: 2729701. DOI: 10.1002/art.23619. View

2.
Wang S, Wang J, Kumar V, Karnell J, Naiman B, Gross P . IL-21 drives expansion and plasma cell differentiation of autoreactive CD11cT-bet B cells in SLE. Nat Commun. 2018; 9(1):1758. PMC: 5931508. DOI: 10.1038/s41467-018-03750-7. View

3.
Jenks S, Cashman K, Woodruff M, Lee F, Sanz I . Extrafollicular responses in humans and SLE. Immunol Rev. 2019; 288(1):136-148. PMC: 6422038. DOI: 10.1111/imr.12741. View

4.
Naradikian M, Myles A, Beiting D, Roberts K, Dawson L, Herati R . Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells. J Immunol. 2016; 197(4):1023-8. PMC: 4975960. DOI: 10.4049/jimmunol.1600522. View

5.
Ruuth K, Carlsson L, Hallberg B, Lundgren E . Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem Biophys Res Commun. 2001; 284(3):583-6. DOI: 10.1006/bbrc.2001.5025. View